Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Hope

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Medical Mycology|March 1, 2014
An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistanceA Gomez-Lopez, A Forastiero, E Cendejas-Bueno, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
Tools for the Individualized Therapy of Teicoplanin for Neonates and ChildrenV Ramos-Martín, M N Neely, K Padmore, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapyV Ramos-Martín, M N Neely, P McGowan, et al.
The Journal of Infection|August 7, 2012
Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortalityT W Felton, S A Roberts, B Isalska, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafunginJ L Slater, S J Howard, A Sharp, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|March 4, 2016
Design and implementation of the Americas Hernia Society Quality Collaborative (AHSQC): improving value in hernia careB K Poulose, S Roll, J W Murphy, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonatesV Ramos-Martín, A Johnson, J Livermore, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Medical Mycology|March 1, 2014
An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistanceA Gomez-Lopez, A Forastiero, E Cendejas-Bueno, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
Tools for the Individualized Therapy of Teicoplanin for Neonates and ChildrenV Ramos-Martín, M N Neely, K Padmore, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapyV Ramos-Martín, M N Neely, P McGowan, et al.
The Journal of Infection|August 7, 2012
Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortalityT W Felton, S A Roberts, B Isalska, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafunginJ L Slater, S J Howard, A Sharp, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|March 4, 2016
Design and implementation of the Americas Hernia Society Quality Collaborative (AHSQC): improving value in hernia careB K Poulose, S Roll, J W Murphy, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonatesV Ramos-Martín, A Johnson, J Livermore, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Pageof 5